[Federal Register: December 1, 1998 (Volume 63, Number 230)]
[Notices]               
[Page 66199]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01de98-129]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Withdrawal

    As set forth in the Federal Register (FR Doc. 98-8085) Vol. 63, No. 
59 at page 14964, dated March 27, 1998, Inhalon Pharmaceuticals, Inc., 
3998 Schelden Circle, Bethlehem, Pennsylvania 18017 made application to 
the Drug Enforcement Administration for registration as a bulk 
manufacturer of amphetamine (1100) and methylphenidate (1724).
    A registered bulk manufacturer of methylphenidate submitted an 
objection to the proposed registration of Inhalon Pharmaceuticals for 
the manufacture of methylphenidate. Inhalon Pharmaceuticals has 
requested that its application be withdrawn. Therefore, Inhalon 
Pharmaceuticals application to manufacture amphetamine and 
methylphenidate is hereby withdrawn.

    Dated: November 18, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-31967 Filed 11-30-98; 8:45 am]
BILLING CODE 4410-09-M